Tom Sheeran

1.3k total citations
33 papers, 488 citations indexed

About

Tom Sheeran is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Tom Sheeran has authored 33 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 8 papers in Immunology and 7 papers in Hematology. Recurrent topics in Tom Sheeran's work include Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). Tom Sheeran is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). Tom Sheeran collaborates with scholars based in United Kingdom, Germany and Spain. Tom Sheeran's co-authors include Paul P. Tak, K. Kissel, Georg Schett, Corrado Bernasconi, F. Navarro-Sarabia, Maxime Dougados, Emilio Martín Mola, Howard Amital, T. Huizinga and Philip G. Conaghan and has published in prestigious journals such as Blood, CHEST Journal and Annals of the Rheumatic Diseases.

In The Last Decade

Tom Sheeran

29 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Sheeran United Kingdom 9 285 172 133 109 72 33 488
Maryam Adas United Kingdom 10 210 0.7× 58 0.3× 79 0.6× 89 0.8× 58 0.8× 37 454
Federica Bevilacqua Italy 10 101 0.4× 303 1.8× 57 0.4× 135 1.2× 124 1.7× 14 732
Chengappa Kavadichanda India 13 231 0.8× 50 0.3× 80 0.6× 112 1.0× 44 0.6× 62 521
U. von Hinüber Germany 8 330 1.2× 67 0.4× 169 1.3× 123 1.1× 23 0.3× 13 449
Claire Masson France 9 122 0.4× 73 0.4× 165 1.2× 133 1.2× 12 0.2× 17 526
N. McHugh United Kingdom 9 292 1.0× 90 0.5× 81 0.6× 384 3.5× 172 2.4× 17 662
Jesús Tornero-Molina Spain 7 466 1.6× 79 0.5× 215 1.6× 122 1.1× 8 0.1× 15 598
Árni Jón Geirsson Iceland 12 254 0.9× 54 0.3× 77 0.6× 184 1.7× 14 0.2× 20 460
Dennis W. Boulware United States 13 138 0.5× 238 1.4× 34 0.3× 90 0.8× 98 1.4× 25 597
José Melo‐Gomes Portugal 8 439 1.5× 78 0.5× 365 2.7× 102 0.9× 10 0.1× 14 733

Countries citing papers authored by Tom Sheeran

Since Specialization
Citations

This map shows the geographic impact of Tom Sheeran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Sheeran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Sheeran more than expected).

Fields of papers citing papers by Tom Sheeran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Sheeran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Sheeran. The network helps show where Tom Sheeran may publish in the future.

Co-authorship network of co-authors of Tom Sheeran

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Sheeran. A scholar is included among the top collaborators of Tom Sheeran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Sheeran. Tom Sheeran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schmalzing, Marc, Francisco Javier de Toro Santos, Rosario Foti, et al.. (2023). Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study. Advances in Therapy. 41(1). 315–330. 1 indexed citations
3.
Gaffney, Karl, Nicola Gullick, Kirsten Mackay, et al.. (2023). Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA. Rheumatology Advances in Practice. 7(3). rkad055–rkad055. 2 indexed citations
4.
Dubey, Shirish, Caroline Gordon, Tom Sheeran, et al.. (2021). Understanding the impact of systemic lupus erythematosus on work amongst South Asian people in the UK: An explorative qualitative study. Lupus. 30(9). 1492–1501. 4 indexed citations
5.
Bateman, James, et al.. (2021). COVID-19 vaccination advice via SMS-based video to improve vaccination uncertainty in at-risk groups. The Lancet Rheumatology. 3(6). e399–e401. 7 indexed citations
6.
Shields, Adrian, Shankara Paneesha, Tom Sheeran, et al.. (2021). Vaccine Efficacy after Rituximab Exposure: First Interim Analysis of Virtue Project on Behalf of West Midlands Research Consortium, UK. Blood. 138(Supplement 1). 196–196. 1 indexed citations
7.
Kumar, Kanta, et al.. (2020). Cardiovascular risk knowledge in patients of South Asian origin living with rheumatoid arthritis: data from India and the UK. BMC Rheumatology. 4(1). 57–57. 3 indexed citations
8.
Bateman, James, et al.. (2020). Rapid distribution of information by SMS-embedded video link to patients during a pandemic. The Lancet Rheumatology. 2(6). e315–e316. 8 indexed citations
9.
Dubey, Shirish, et al.. (2020). Testing the waters: COVID‐19 first wave and shielding among BAME patients with rheumatological conditions in the United Kingdom. Musculoskeletal Care. 19(2). 244–246. 1 indexed citations
10.
Zahid, Adnan, et al.. (2019). A COMBINED RHEUMATOLOGY/NTERSTITIAL LUNG DISEASE SERVICE: THE WOLVERHAMPTON EXPERIENCE. CHEST Journal. 155(4). 139A–139A. 1 indexed citations
11.
Naz, Sophia, et al.. (2018). Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland. Advances in Therapy. 35(9). 1426–1437. 6 indexed citations
12.
Packham, Jon, et al.. (2017). Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication: a quantitative study. Clinical Rheumatology. 36(11). 2595–2600. 12 indexed citations
13.
14.
15.
16.
17.
Salam, Abdul, et al.. (2008). Acute onset polyarthritis in older people: Is it RS3PE syndrome?. Cases Journal. 1(1). 132–132. 10 indexed citations
18.
Gough, Andrew, Tom Sheeran, Paul Bacon, & P. Emery. (1998). Dietary advice in systemic sclerosis: the dangers of a high fibre diet. Annals of the Rheumatic Diseases. 57(11). 641–642. 7 indexed citations
19.
Brennan, Paul, Alan J. Silman, C Black, et al.. (1993). VALIDITY AND RELIABILITY OF THREE METHODS USED IN THE DIAGNOSIS OF RAYNAUD'S PHENOMENON. Lara D. Veeken. 32(5). 357–361. 70 indexed citations
20.
Brennan, Paul, Alan J. Silman, C Black, et al.. (1992). RELIABILITY OF SKIN INVOLVEMENT MEASURES IN SCLERODERMA. Lara D. Veeken. 31(7). 457–460. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryam Adas Breakdown of academic impact, for papers by Federica Bevilacqua Breakdown of academic impact, for papers by Chengappa Kavadichanda Breakdown of academic impact, for papers by U. von Hinüber Breakdown of academic impact, for papers by Claire Masson Breakdown of academic impact, for papers by N. McHugh Breakdown of academic impact, for papers by Jesús Tornero-Molina Breakdown of academic impact, for papers by Árni Jón Geirsson Breakdown of academic impact, for papers by Dennis W. Boulware Breakdown of academic impact, for papers by José Melo‐Gomes
Rankless by CCL
2026